METASTATIC TRIPLE NEGATIVE BREAST CANCER
Clinical trials for METASTATIC TRIPLE NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TRIPLE NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC TRIPLE NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for aggressive breast cancer
Disease control CompletedThis small pilot study tested whether combining two drugs—veliparib and lapatinib—could help control metastatic triple negative breast cancer in patients who had already tried other treatments. The main goal was to check if the combination was safe and tolerable, while also looki…
Matched conditions: METASTATIC TRIPLE NEGATIVE BREAST CANCER
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New pill tested for aggressive breast cancer
Disease control CompletedThis early-stage trial tested a daily pill called leflunomide in women with metastatic triple negative breast cancer (TNBC), a hard-to-treat form of the disease. The study first aimed to find a safe dose and then to see if the drug could help control the cancer. It involved 17 wo…
Matched conditions: METASTATIC TRIPLE NEGATIVE BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Joseph Sparano • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC